A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
复制标题
DOI：
10.1016/s0959-8049(01)00083-1
复制
发表时间：
2001-06-01
影响因子：
8.4
通讯作者：
Verweij, J
中科院分区：
文献类型：
--
作者：
Gortzak, E;Azzarelli, A;Verweij, J
本研究的目的是探讨成人高风险软组织肉瘤患者采用阿霉素和异环磷酰胺联合新辅助化疗的策略、可行性和结果。“高风险”软组织肉瘤患者，定义为肿瘤大于或等于8cm的任何级别，或II/III级肿瘤
The aim of this study was to examine the strategy, feasibility and outcome of neo-adjuvant chemotherapy, with doxorubicin and ifosfamide, in adult patients with 'high-risk' soft-tissue sarcomas. patients with 'high-risk' soft-tissue sarcomas, defined as tumours greater than or equal to8 cm of any grade, or grade II/III tumours